Alkem Laboratories (ALKEM): Press Release

Press Release Alkem Laboratories Limited has informed the Exchange regarding a press release dated Jun 02, 2026, titled "Alkem Laboratories Limited becomes first in India to launch semaglutide in single-shot pre-filled syringes at price starting INR350.". Alkem Laboratories Limited has informed the Exchange regarding a press release dated Jun 02, 2026, titled "Alkem Laboratories Limited becomes first in India to launch semaglutide in single-shot pre-filled syringes at price starting INR350.".

1 min read Alkem Laboratories

Press Release

Press Release

Alkem Laboratories Limited has informed the Exchange regarding a press release dated Jun 02, 2026, titled "Alkem Laboratories Limited becomes first in India to launch semaglutide in single-shot pre-filled syringes at price starting INR350.".

Alkem Laboratories Limited has informed the Exchange regarding a press release dated Jun 02, 2026, titled "Alkem Laboratories Limited becomes first in India to launch semaglutide in single-shot pre-filled syringes at price starting INR350.".

Disclaimer

This article is for informational purposes only and is not investment advice. Verify all figures and announcements from official exchange filings and company disclosures before making decisions.

#Alkem Laboratories Ltd #ALKEM #Corporate announcement

Track Indian stocks with ZTOX AI

Get started free

Track Indian stocks with ZTOX AI

NSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.

Insider Deals Alert
Volume Breakouts
Block Deal Notifications
Preferential Issue Alerts
Free ₹0
Basic ₹89/mo
Advanced ₹119/mo
No credit card required to start on the free plan.
Start Free Now